BioNTech SE (BNTX) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-10 17:40:18 ET
BioNTech SE (BNTX) Q4 2025 Earnings Call March 10, 2026 8:00 AM EDT
Company Participants
Douglas Maffei - Vice President of Strategy & Investor Relations
Ugur Sahin - Co-Founder, CEO & Chair of the Management Board
Özlem Türeci - Co-Founder, Chief Medical Officer & Member of Management Board
Ramón Zapata-Gomez - CFO & Member of Management Board
...
Read the full article on Seeking Alpha
For further details see:
BioNTech SE (BNTX) Q4 2025 Earnings Call Transcript
BioNTech SE
NASDAQ: BNTX
BNTX Trading
-20.41% G/L:
$80.30 Last:
8,115,591 Volume:
$82.81 Open:
BNTX Latest News
BNTX Stock Data
$26,377,590,776
95,508,380
N/A
104
N/A
Biotechnology & Life Sciences
Healthcare
DE
Mainz
